CrunchBase : The Week’s 10 Biggest Funding Rounds: Cybersecurity Leads With Kite

The Week’s 10 Biggest Funding Rounds: Cybersecurity Leads With Kiteworks’ Nearly Half-Billion-Dollar Deal

This week definitely saw a slowdown in big rounds, with only three deals breaking the $100 million mark. However, healthcare and medical device makers did well. Perhaps announcements are slowing as summer is coming to a close, but the week certainly seemed to lack the big money of so many this year.

1. Kiteworks, $456M, cybersecurity: Investors seem to be digging cybersecurity yet again. A week after Abnormal Security closed a $250 million Series D that valued the startup at $5.1 billion, secure content company Kiteworks raised a $456 million round from Insight Partners (which also participated in the Abnormal round) and Sixth Street. The San Mateo, California-based company described the new round as “growth equity,” but also said it was a “partial liquidity event,” meaning some investors were able to cash out. While the company did not specify a valuation, it did state it was a minority investment, meaning its valuation is greater than $1 billion. Kiteworks’ platform allows customers to share sensitive data with other trusted parties via communication channels such as email and file sharing. In 2020 the company raised $120 million in a funding round led by Bregal Sagemount. Founded in 1999, Kiteworks has raised $592 million. The company was formerly known as Accellion and suffered a major data breach in 2021.

2. Halda Therapeutics, $126M, biotech: The big biotech round of the week came from New Haven, Connecticut-based Halda Therapeutics, a biotech startup developing therapies for prostate cancer and breast cancer, which raised a $126 million Series B extension from investors including Deep Track Capital and RA Capital Management. Founded in 2018, Halda has raised $202 million to date, per the company.

3. HistoSonics, $102M, healthcare: Usually we talk a lot about biotechs in this column, but this week was a good week for healthcare and medical device companies like HistoSonics. The Minneapolis company raised a $102 million Series D led by Alpha Wave Ventures. The startup’s Edison Histotripsy System uses ultrasound to create a “bubble cloud” designed to destroy and liquefy targeted liver tumors. Founded in 2009, the company has raised nearly $329 million, per Crunchbase.

4. Neptune Medical, $97M, medical device: Like we said, a good week for medical device makers as Neptune Medical raised big, too. The Burlingame, California-based medical device maker locked up a $97 million Series D. The company said Olympus and Sonder Capital were significant participants in this round. Neptune Medical is focused on using robotics to combat gastrointestinal disease. Founded in 2016, this is the company’s first disclosed funding amount, per Crunchbase.

5. Caresyntax, $80M, healthcare: We stay on healthcare, with Caresyntax’s $180 million raise through a series C extension and growth debt expansion round. The money breakdown is $80 million in equity and a $100 million growth debt facility from a variety of investors. The San Francisco-based startup has developed software and an AI platform for surgery — allowing for the use of data and applications to enhance surgical precision and patient safety. Founded in 2013, the company has raised nearly $388 million, per Crunchbase.

6. EliseAI, $75M, artificial intelligence: Conversational AI platform EliseAI was minted one of the newest unicorns in the AI world. The New York-based company raised a $75 million Series D at a valuation in excess of $1 billion led by Sapphire Ventures. EliseAI currently focuses its AI platform on the housing industry, but is also expanding into healthcare. Founded in 2017, the company has raised nearly $142 million, per Crunchbase.

7. Chaos Labs, $55M, blockchain: New York-based Chaos Labs, a blockchain risk management startup, raised a $55 million Series A led by Haun Ventures. Founded in 2022, the company has raised $75 million, per Crunchbase.

8. Moximed, $61M, medical device: Fremont, California-based Moximed, a developer of medical devices for people with knee osteoarthritis, closed a $61 million Series D, which also includes an option to close on up to an additional $30 million. The round was led by Elevage Medical Technologies. Founded in 2006, the company has raised $244 million, per Crunchbase.

9. Sahara AI, $43M, artificial intelligence: Los Angeles-based Sahara AI, a decentralized AI network, raised a $43 million funding round led by venture capital investors Binance Labs, Pantera Capital and Polychain. Founded in 2023, the company has raised $49 million, per Crunchbase.

10. PayZen, $32M, fintech: San Francisco-based PayZen, a fintech startup for the healthcare industry, raised $32 million in equity led by NEA. The company also raised a $200 million credit facility. Founded in 2019, the company has raised $472 million, per Crunchbase.

FT : Secret superyacht trips and fake documents: how H2O tried to cover up a sca

Secret superyacht trips and fake documents: how H2O tried to cover up a scandal
UK watchdog accused firm of misleading it over ties to financier Lars Windhorst

In the summer of 2019, H2O Asset Management faced a dilemma.

The UK’s Financial Conduct Authority had just asked the firm to hand over documents relating to a series of controversial investments it had made that were linked to a racy financier with a criminal past.

The regulator’s demand capped a torrid month for the asset manager. An investigation by the Financial Times had recently revealed that it had poured substantial amounts of investor money into these illiquid securities, which led nervous clients to withdraw €8bn from the €34bn of funds it managed.

While the investor exodus had slowed, the request for evidence of the research and valuation work H2O had carried out posed a major problem: the firm had often performed little or no due diligence before buying the bonds and stocks, the FCA later found, while a valuation committee that was supposed to scrutinise the investments had not met for months.

Rather than owning up to these lax checks and balances, however, certain H2O employees falsified documents and even fabricated minutes of meetings that had never taken place, according to findings the British regulator published last week after a five-year investigation.

At the same time, H2O tried to hide from the regulator that its senior managers had for years been wined and dined by Lars Windhorst — the notorious financier behind its illiquid investments — who had lavished the firm’s top brass with trips around the world on his private jet and superyacht.

When the FCA initially probed its dealings with the financier, H2O indicated that it had received no gifts and entertainment from Windhorst, the regulator revealed last week.

The alleged cover-up burst into public view when H2O last week agreed to pay €250mn to investors to help avoid a fine from the FCA, which described its regulatory breaches as “extremely serious”. The FCA accused H2O of attempting to “conceal certain matters” in order to “hide the severity of its due diligence and systems and controls failings”.

While H2O said last week that it has since overhauled its “risk management and compliance teams, governance and internal procedures”, the FCA’s findings, along with further internal correspondence and other documents seen by the FT, paint a stark picture of the lengths H2O went to conceal its risky dealings from both the authorities and its investors.

Blurred lines
On a spring day in 2018, Bruno Crastes sat down to enjoy a birthday meal like no other.

The then 53-year-old Frenchman’s buccaneering approach to trading government bonds and currencies had made H2O — which he had co-founded with backing from French bank Natixis at the start of the decade — one of the most revered investment firms in Europe.

That evening, according to people familiar with the event, Crastes celebrated his birthday aboard a superyacht moored in Monaco belonging to the man who would ultimately prove central to his downfall: Windhorst.

The German financier possessed an uncanny ability to attract deep-pocketed backers despite a career defined by scandal. Yet H2O handed Windhorst unprecedented financial firepower, providing him with funding to buy everything from luxury lingerie maker La Perla to German football club Hertha Berlin. 

These hard-to-value private debt deals were a major departure for H2O, whose name alluded to the liquidity and transparency it was supposed to offer clients. By the time French and British regulators restricted H2O from investing more with Windhorst in 2020, it had well over €2bn of exposure to his businesses.

Over the years, Crastes’ professional and personal relationship with Windhorst became increasingly blurred. In addition to his 2018 birthday meal, Crastes took numerous trips on the financier’s 240ft-long superyacht, Global, even bringing his family along for the ride on sojourns to the Mediterranean and Caribbean.

Then, in February 2019, Windhorst announced to executives at La Perla that Crastes’ wife would become general manager of a new flagship store in Monaco. That same day, according to correspondence seen by the FT, Windhorst emailed Crastes to let him know he had purchased 32 bottles of 1982 vintage Château Latour wine, which the H2O chief replied they needed “to celebrate La Perla Monaco”.

Crastes’ wife did not end up taking a job at La Perla, however, which ultimately shelved plans for the Monaco store.

At the time, few people at H2O knew the full extent of Crastes’ personal entanglements with the financier, with the FCA noting that several members of H2O’s risk and compliance committee had “never heard of Mr Windhorst” before the FT’s reporting. 

That was all about to change. 

‘Purely business’
In June 2019, the FT published an investigation detailing the extent of H2O’s illiquid investments linked to Windhorst, sparking a market panic that led investors to withdraw billions of euros from its funds.

In video messages to clients following publication, Crastes described H2O’s relationship with Windhorst as “purely business”, while the firm’s chief investment officer Vincent Chailley assured investors that the firm applied “strict internal limits” to illiquid assets. 

Just two weeks earlier, however, Chailley had emailed Windhorst complaining that H2O had been “breaching [risk limits] for more than six months on a number of funds” due to their exposure to his debt, adding that two of its funds were now “struggling with liquidity”.

While H2O’s calming words assuaged many concerned clients, the following month the FCA began requesting various documents from H2O relating to its due diligence and valuation processes.

While H2O’s funds had several different portfolio managers, the FCA later found that Crastes and Chailley in practice “made all the decisions” to invest in the Windhorst-linked deals.

They often agreed to invest with little of the documentation investors usually require for high-risk bonds. Some of the underlying businesses were little more than shell companies when H2O funded them, with few restrictions on how Windhorst spent the proceeds.

H2O had already started to backfill some of these gaps before the regulator’s request, according to both correspondence seen by the FT and the FCA findings. One of its portfolio managers emailed Windhorst’s investment company, Tennor, in late June to request prior financial statements and corporate presentations “following the FT article”.

Then in the second half of 2019, H2O provided the FCA with due diligence reports and other documents that it said had been prepared when it invested. However, the FCA later identified that all of these documents had been “prepared retrospectively”, either directly in response to its requests or during what it called a “repapering exercise” after the FT story. 

The FCA said that these efforts were led by an unnamed member of H2O’s senior management — dubbed “Senior Manager A” in the regulatory findings — who “knowingly made the false statements and provided the falsified documents”. 

The executive in question was in charge of H2O’s risk and compliance function, according to people familiar with the matter, and left the firm in 2021 after being suspended following an internal investigation into the matter.

The FCA said that Senior Manager A also provided the regulator with retrospectively created minutes for meetings of H2O’s valuation and risk and compliance committees, in some instances when meetings had never taken place.

The FCA noted that there was “extensive discussion” at H2O “regarding the retrospective creation of documents”, with one former employee even suggesting the use of “specialist software to amend metadata” on files. However, the FCA noted that H2O did not ultimately make use of this software.

Another employee warned others about the danger of backdating documents, writing: “If the FCA has a way of finding out that we have changed these dates, the risk is obviously considerable.” 

H2O also tried to stonewall the regulator as it probed the extensive hospitality Windhorst had bestowed upon its staff.

H2O initially told the FCA in October 2019 that its gifts and entertainment register showed that “nothing was given or received” from entities linked to Windhorst. 

When the FCA then asked H2O to provide details of any trips taken with Windhorst — specifically requesting details of “meetings on yachts, airplanes and private properties” — H2O only listed business meetings mostly in Windhorst’s London offices and “two specific overseas trips” more junior staff took to visit some of his companies.

After a third-party review mandated by the FCA began to uncover details of many of the trips senior staff took aboard Windhorst’s superyacht and private jet, the regulator instructed H2O to carry out another targeted search. 

This returned over 50 instances of H2O staff “receiving hospitality (and occasionally gifts)” from the financier — such as “Mr Crastes being flown to Barbados to play golf with Mr Windhorst” — and 18 more times where Windhorst had offered hospitality but there was “no confirmation of its acceptance or receipt.”

H2O also initially denied to the FCA that “any personal relationships (such as friendships)” existed between its staff and Windhorst. 

But the regulator later uncovered a January 2019 email in which Crastes thanked Windhorst for arranging a family holiday in the Caribbean, describing the financier as “my friend” and akin to a “new family” member.

Windhorst declined to comment for this article.

H2O said that “the lessons from the 2015-2019 period are fully embedded in our corporate culture and organisation”

It added: “The FCA has distinctly acknowledged H2O’s significant enhancements in its governance, systems, and controls. These improvements include adoption and implementation of a new governance model with changes to senior management roles and responsibilities and undertaking a culture review and change programme, as well as enhancements to policies and procedures.”

As part of its settlement with the FCA, H2O will apply to cancel its UK regulatory authorisation, although it still intends to maintain a London office with staff in non-regulated functions.

While the UK capital was once H2O’s main base, it has restructured in recent years and shifted staff to Paris and Monaco.

French regulators last year struck off Crastes from managing funds for half a decade. Monaco-based Crastes is no longer chief executive of the firm but he has continued to play an active role at the firm as its “corporate and market strategy director”. H2O also received a record €75mn fine from the Autorité des Marchés Financiers. Both Crastes and H2O are appealing against their AMF sanctions.

Meanwhile, Windhorst has only repaid a fraction of his debts to H2O, which has heavily written down the rest. He recently unveiled a new high-profile backer: British financier Nathaniel Rothschild last month agreed to take a minority stake in his investment firm and become its executive chair.

“I’ve never seen anyone who works quite as hard as Lars,” Rothschild told an audience at Windhorst’s Mayfair offices. “It’s quite remarkable.”

>>> Europe : Brokers Upgrades & Downgrades - 16th of August 2024 V3(++)

>>> Up
* Administer Raised to Accumulate at Inderes; PT 3.20 euros
* Big Yellow Group Raised to Buy at Citi; PT 1,525 pence
* Campari Raised to Buy at HSBC; PT 10 euros
* Cisco Raised to Buy at HSBC; PT $58
* Entain Raised to Neutral at Goldman; PT 710 pence
* Fastned GDRs Raised to Buy at Kempen & Co; PT 21 euros (++)
* Marimekko Raised to Accumulate at Inderes; PT 13 euros
* Millicom Raised to Buy at UBS; PT $33
* RING NO Raised to Buy at Pareto Securities; PT 330 kroner (++)
* Roche PT Raised from CHF 248 to CHF 274 at Vontobel
* SpareBank 1 Helgeland Raised to Buy at Arctic Securities (+)
* Tamtron Group Raised to Accumulate at Inderes; PT 6 euros
* Vopak PT Raised to 51 euros from 46 euros at ING (++)
* Walmart PT Raised to $82 from $75 at Morgan Stanley

>>> Down
* Alm Brand Cut to Hold at Nordea (+)
* Autostore PT Cut to 10 kroner from 11 kroner at Morgan Stanley
* Bioretec Cut to Reduce at Inderes; PT 3 euros
* Cancom Cut to Underperform at BNPP Exane; PT 26 euros
* Crest Nicholson Cut to Equal-Weight at Barclays; PT 220 pence
* Estee Lauder Cut to Neutral at BofA; PT $100 (++)
* Fortum Cut to Reduce at Inderes; PT 14.50 euros
* Kojamo Cut to Neutral at JPMorgan; PT 10.50 euros
* Kojamo Cut to Accumulate at OP Corporate Bank; PT 10.50 euros (++)
* Nel Cut to Hold at Berenberg; PT 7 kroner
* Relais Group Cut to Accumulate at Inderes; PT 16.50 euros
* Scout24 SE Cut to Hold at M.M. Warburg; PT 75 euros (+)
* Siegfried Cut to Hold at Research Partners; PT 990 Swiss francs
* Thyssenkrupp Nucera Cut to Hold at Berenberg; PT 12 euros

>>> Initiation


>>> Call
* Building-Materials Sector Metamorphosis Sets Scene for Robust 2H
* Big Yellow Group Upgraded at Citi, PT Boosted to Street-High
* Campari Plays Catch-Up; HSBC Upgrades on Scope to Outperform (++)
* Credit Agricole's Shares to Remain Under Pressure, Berenberg Says -- Market Talk (+)
* Deutsche Bank CIO Urges Tail-Risk Hedging Despite Market Calm
* Inditex Worth Premium, H&M Waiting for Signs of Inflection: Citi
* Nel, Thyssenkrupp Nucera Cut at Berenberg on Regulatory Delays
* European Airlines Need Demand Floor as Fares Hit, EPS at Risk

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • AMCR -3.4%, AMAT -2%, RNW -1.5%
Other news:
  • SNDA -15.9% (prices 4.3 mln shares of common stock at $27.00 per share)
  • EVEX -4.7% (files to delay 10-Q)
  • ADSK -1.7% (using controversial sales practice despite pledging to stop, according to Bloomberg)
  • MASI -1.1% (provides update on potential separation of consumer business)
  • RIVN -0.7% (pauses production of Amazon (AMZN) delivery truck amid part shortages, according to Bloomberg)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • HRB +8.3% (also files mixed shelf securities offering; also increases dividend by 17%; new $1.5 bln share repurchase authorization), GLOB +5.6%, ALVO +4.8%, SGML +4.6%, MSGE +4.1%, COHR +3.8%, DESP +0.7%
Other news:
  • PL +8.3% (first hyperspectral satellite will launch on Aug 16)
  • TPC +6% (wins $1.66 bln award for City Center Guideway and Stations Project in Honolulu)
  • QTRX +5.7% (President & CEO bought 19,000 shares at $10.88 - $10.90 worth about $207K)
  • PGRU +5.6% (to be acquired by EQT Private Capital Asia for $1.1 bln)
  • TMCI +4.8% (CEO bought 85,000 shares at $5.95 - $6.07 worth approx. $510K)
  • PLSE +4.2% (to delay 10-Q filing)
  • LQDA +2.7% (Announces Poster Presentations at the PHA 2024 International PH Conference and Scientific Sessions)
  • VCEL +2.5% (FDA approves NexoBrid for severe thermal burns)
  • CACI +2.4% (awarded $239 mln US Army task order)
  • BWMN +2.2% (authorizes increase in its share repurchase program)
  • PTLO +2% (Engaged Capital affirmed yesterday active stake in Portillo's)
  • WBTN +1.9% (following insider buy disclosures)
  • ATR +1.7% (FDA approves Unidose delivery system with neffy for the emergency treatment of patients with allergic reactions)
  • MUSA +1.6% (increases dividend)
  • MDWD +1.5% (FDA approves NexoBrid for severe thermal burns)
  • TXN +1.5% (signs preliminary agreement to receive up to $1.6 bln in CHIPS and Science Act for funding for semiconductor manufacturing in Utah and Texas) MDU +1.2% (increases dividend)
  • FLEX +1.1% (files mixed shelf securities offering)
  • LOT +1.1% (reports it provides intelligent driving solutions for Lynk&Co's first all-electric sedan)
  • UCB +1.1% (raises dividend)

>>> US Research Calls I

Research Calls I
  • Upgrades:
    • AFC Gamma (AFCG) upgraded to Neutral from Sell at Compass Point; tgt lowered to $9
    • CF Industries (CF) upgraded to Overweight from Equal Weight at Barclays; tgt raised to $90
    • Cisco (CSCO) upgraded to Buy from Hold at HSBC Securities; tgt raised to $58
    • Fox Corporation (FOXA) upgraded to Overweight from Underweight at Wells Fargo; tgt raised to $46
    • Illumina (ILMN) upgraded to Buy from Neutral at Daiwa Securities; tgt raised to $154
    • Kimco Realty (KIM) upgraded to Strong Buy from Mkt Perform at Raymond James; tgt $25
    • Kite Realty (KRG) upgraded to Strong Buy from Mkt Perform at Raymond James; tgt $28
    • Microchip (MCHP) upgraded to Overweight from Neutral at Piper Sandler; tgt raised to $100
    • Newmark Group (NMRK) upgraded to Outperform from Peer Perform at Wolfe Research; tgt $15
    • NIKE (NKE) upgraded to Buy from Sell at Williams Trading
    • Origin Materials (ORGN) upgraded to Buy from Neutral at BofA Securities; tgt raised to $3
    • Sphere Entertainment Co. (SPHR) upgraded to Overweight from Neutral at JP Morgan; tgt raised to $57
    • Teradyne (TER) upgraded to Overweight from Neutral at Cantor Fitzgerald; tgt $16
  • Downgrades:
    • Bumble Inc. (BMBL) downgraded to Hold from Buy at TD Cowen; tgt lowered to $7.50
    • CAE (CAE) downgraded to Equal-Weight from Overweight at Morgan Stanley
    • Coherus BioSciences (CHRS) downgraded to Neutral from Buy at UBS; tgt lowered to $1.50
    • Estee Lauder (EL) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $100
    • Lumen Technologies (LUMN) downgraded to Underweight from Equal Weight at Wells Fargo; tgt raised to $4
    • Silicon Motion (SIMO) downgraded to Underperform from Buy at BofA Securities; tgt lowered to $60
    • Viracta Therapeutics (VIRX) downgraded to Market Perform from Outperform at Leerink Partners; tgt lowered to $3
    • Vital Energy (VTLE) downgraded to Sector Weight from Overweight at KeyBanc Capital Markets
    • Xos (XOS) downgraded to Neutral from Buy at DA Davidson; tgt lowered to $9
  • Others:
    • Couchbase (BASE) initiated with an Overweight at Piper Sandler; tgt $22
    • Liquidia Technologies (LQDA) initiated with an Outperform at Raymond James; tgt $27
    • Palo Alto Networks (PANW) addded to Evercore ISI's Tactical Underperform List
    • Two Harbors Investment (TWO) initiated with a Buy at Janney; tgt $15
    • Y-mAbs Therapeutics (YMAB) initiated with an Overweight at Cantor Fitzgerald; tgt $20

>>> US Early premarket gappers

Early premarket gappers
  • Gapping up:
    • PL +14.3%, TPC +6.9%, ALVO +6.2%, HRB +6.1%, SGML +5.8%, PGRU +5.6%, GLOB +5.6%, PLSE +4.2%, COHR +3.1%, MDWD +3%, LQDA +2.7%, VCEL +2.5%, CACI +2.2%, INCY +2.1%, PTLO +2%, BTDR +1.9%, ATR +1.7%, TXN +1.7%, MUSA +1.6%, DESP +1.4%, MDU +1.2%, FLEX +1.1%, LOT +1.1%, KR +1.1%, UCB +1.1%
  • Gapping down:
    • SNDA -15.9%, AMCR -7.5%, EVEX -4.7%, AMAT -3.2%, RNW -2.9%, ADSK -1.7%, GTES -0.9%

>>> Europe : Brokers Upgrades & Downgrades - 16th of August 2024 V2(+)

>>> Up
* Administer Raised to Accumulate at Inderes; PT 3.20 euros
* Big Yellow Group Raised to Buy at Citi; PT 1,525 pence
* Campari Raised to Buy at HSBC; PT 10 euros
* Cisco Raised to Buy at HSBC; PT $58
* Entain Raised to Neutral at Goldman; PT 710 pence
* Marimekko Raised to Accumulate at Inderes; PT 13 euros
* Millicom Raised to Buy at UBS; PT $33
* Roche PT Raised from CHF 248 to CHF 274 at Vontobel
* SpareBank 1 Helgeland Raised to Buy at Arctic Securities (+)
* Tamtron Group Raised to Accumulate at Inderes; PT 6 euros
* Walmart PT Raised to $82 from $75 at Morgan Stanley

>>> Down
* Alm Brand Cut to Hold at Nordea (+)
* Autostore PT Cut to 10 kroner from 11 kroner at Morgan Stanley
* Bioretec Cut to Reduce at Inderes; PT 3 euros
* Cancom Cut to Underperform at BNPP Exane; PT 26 euros
* Crest Nicholson Cut to Equal-Weight at Barclays; PT 220 pence
* Fortum Cut to Reduce at Inderes; PT 14.50 euros
* Kojamo Cut to Neutral at JPMorgan; PT 10.50 euros
* Nel Cut to Hold at Berenberg; PT 7 kroner
* Relais Group Cut to Accumulate at Inderes; PT 16.50 euros
* Scout24 SE Cut to Hold at M.M. Warburg; PT 75 euros (+)
* Siegfried Cut to Hold at Research Partners; PT 990 Swiss francs
* Thyssenkrupp Nucera Cut to Hold at Berenberg; PT 12 euros

>>> Initiation


>>> Call
* Building-Materials Sector Metamorphosis Sets Scene for Robust 2H
* Big Yellow Group Upgraded at Citi, PT Boosted to Street-High
* Credit Agricole's Shares to Remain Under Pressure, Berenberg Says -- Market Talk (+)
* Deutsche Bank CIO Urges Tail-Risk Hedging Despite Market Calm
* Inditex Worth Premium, H&M Waiting for Signs of Inflection: Citi
* Nel, Thyssenkrupp Nucera Cut at Berenberg on Regulatory Delays
* European Airlines Need Demand Floor as Fares Hit, EPS at Risk